TSC2 and lymphangioleiomyomatosis: Since ECs in patients with LAM and in Tbx4LME-CreTsc2fl/fl mice did not harbor TSC2 mutations, our study demonstrates that constitutively active mTORC1 lung mesenchymal cells orchestrated dysfunctional EC responses that contributed to pulmonary vascular remodeling.